# Danish pharmaceutical giant Novo Nordisk reported an adjusted operating profit of 32.86 billion Danish crowns.

*biotech · news · 2026-05-06 · Devdiscourse*

## Key points

- Novo Nordisk's Q1 adjusted operating profit reached 32.86 billion crowns, surpassing projections.
- Sales of the new Wegovy weight-loss pill drove Novo's better-than-expected financial results.
- Novo revised its adjusted sales and profit decline outlook to 4%-12%, an improved estimate.
- Novo Nordisk is leveraging Wegovy's success amid new competition from Eli Lilly's Foundayo drug.

**Companies:** Novo Nordisk, Eli Lilly
**Countries:** Denmark, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/business/3898237-novo-nordisk-surges-with-wegovy-success-amid-eli-lilly-rivalry)

---

Canonical: https://newsio.io/n/62a48f99-f232-4ced-a768-447f7eabe3e3/danish-pharmaceutical-giant-novo-nordisk-reported-an-adjusted-operating-profit-o
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works